• 李克强:扩大跨省异地就医直接结算范围 2019-08-11
  • 次仁卓玛一家的端午节 2019-08-11
  • 市人大常委会召开党组会议传达学习全国两会精神张轩主持并讲话 2019-08-09
  • 世界杯期间在家撸串的正确姿势-热门标签-华商网数码 2019-08-06
  • 兴业银行获第十二届人民企业社会责任奖年度企业奖 2019-08-02
  • 宝马中国创新日暨上海研发中心揭幕 专注于高新技术 2019-08-01
  • 解放军报评论员:担当起党和人民赋予的新时代使命任务 2019-08-01
  • 别人家的中年男子 听音识木一把琴能卖30万 2019-07-18
  • 《贪婪之秋》延期至2019年 E3新宣传片公开 2019-06-25
  • 《关于发展租赁型职工集体宿舍的意见(试行)》正式发布实施 2019-06-24
  • 网约车陷阱多 谨防四类风险 2019-06-19
  • 太原设禁鸣路段 设备在测试中 2019-06-19
  • 歌浴森专辑写真曝光 俏皮可爱萌态十足 2019-06-09
  • 破11个赛季不胜魔咒 山东客场击败广厦 2019-06-09
  • 喝了6瓶劲酒和1斤白酒 男子手持钢锯在重庆西站撒泼遭控制 2019-06-01
  • 来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置时时彩网络平台>技术资料首页>行业动态>行业动态>干细胞治疗市场研究报告

    江苏快3开奖结果: 干细胞治疗市场研究报告

    互联网2009年5月12日 15:09 点击:2014

    时时彩网络平台 www.qlgr.net 干细胞治疗市场研究报告——Stem Cell Therapeutics Markets
     

    Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research.

     

    With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.

    While companies have found opportunity outside the U.S., President Bush's seven year limitations on embryonic stem cell research in the U.S. has limited the U.S. market. Changes in U.S. policy should open up U.S. markets. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells Therapeutics Markets. Kalorama analyst Alison Sahoo has built models to determine the best case and most likely case scenarios for therapeutic markets for stem cells in the coming years. This report breaks down forecasted revenues and procedure volumes for stem cell technologies for these segments in the following disease areas:

    • Cardiovascular disease
    • Lung disease
    • Arthritis
    • Incontinence
    • Osteoporosis
    • Diabetes
    • Cancer
    • Orthopedics
    • Infertility
    • Alzheimer’s disease
    • Burns (severe)
    • Lupus
    • Parkinson’s disease
    • Liver failure
    • Multiple sclerosis
    • Critical limb ischemia
    • Crohn's disease
    • Sickle cell disease
    • Multiple myeloma
    • NH lymphoma
    • Leukemia

    Ths report is the result of exclusive interviews with executives in the stem cell industry, a review of medical and company literature, government databases and publications. As part of this comprehensive analysis of stem cell markets, the following companies were profiled:

    • Aastrom Biosciences
    • Advanced Cell Technologies
    • Brainstorm Cell Therapeutics
    • Celegene
    • ES Cell International
    • Medistem
    • Neostem
    • Opexa Therapeutics
    • Osiris Therapeutics
    • Plureon
    • Regenetech
    • Revivicor
    • Stem Cell Sciences
    • StemLifeLine
    • ThermoGenesis
    • VetCell Bioscience

    目录及图表

    TABLE OF CONTENTS

    CHAPTER ONE: EXECUTIVE SUMMARY

    • Recent Developments
    • Introduction
    • Current Stem Cell Therapies
    • Developmental Stem Cell Therapies
    • Issues in Stem Cell Research
    • Stem Cell Forecasts
    • Market Forecast
    • The Promise of Stem Cells in Medical Treatment
    • Types of Stem Cells
    • Embryonic Stem Cells
    • Important Developments in ES Cell Research
    • Adult Stem Cells
    • Important Developments
    • Scope and Methodology

    CHAPTER TWO: CURRENT STEM CELL THERAPIES

    • Cancer
    • Leukemia
    • Gene Therapy
    • Multiple Myeloma
    • Non-Hodgkin’s Lymphoma Noncancerous Diseases
      • Aplastic Anemia
      • Immunodeficiency
      • Lupus
      • Sickle Cell Disease
      • Other Conditions

    CHAPTER THREE: DEVELOPMENTAL STEM CELL THERAPIES

    • Alzheimer’s Disease
    • Arthritis
    • Burns
    • Cancer
    • Cardiovascular Conditions
    • Critical Limb Ischemia
    • Crohn’s Disease
    • Diabetes
    • Incontinence
    • Infertility
    • Liver Failure
    • Lung Disease
    • Multiple Sclerosis
    • Orthopedics
    • Osteoporosis
    • Parkinson’s Disease
    • Sickle Cell Disease

    CHAPTER FOUR: STEM CELL MARKET FORECASTS

    • Best Case
      • Forecasts By Disease Area
      • Alzheimer’s Disease
      • Arthritis
      • Burns
      • Cancer,
      • Cardiovascular Conditions
      • Critical Limb Ischemia
      • Crohn’s Disease
      • Diabetes,
      • Incontinence
      • Infertility,
      • Liver Failure
      • Lung Disease
      • Multiple Sclerosis
      • Orthopedics
      • Osteoporosis
      • Parkinson’s Disease
      • Sickle Cell Disease
    • Most Likely Case
      • Forecasts By Disease Area
      • Alzheimer’s Disease
      • Arthritis
      • Burns
      • Cancer,
      • Cardiovascular Conditions
      • Critical Limb Ischemia
      • Crohn’s Disease
      • Diabetes,
      • Incontinence
      • Infertility,
      • Liver Failure
      • Lung Disease
      • Multiple Sclerosis
      • Orthopedics
      • Osteoporosis
      • Parkinson’s Disease
      • Sickle Cell Disease

    CHAPTER FIVE: COMPANY PROFILES

    • Aastrom Biosciences
    • Advanced Cell Technologies
    • Athersys
    • Brainstorm Cell Therapeutics
    • Celegene
    • ES Cell International
    • Medistem
    • MultiCell Technologies, Inc.
    • Neostem
    • Nephros Therapeutics, Inc.
    • Opexa Therapeutics
    • Osiris Therapeutics
    • Plureon
    • Regenetech
    • Revivicor
    • Stem Cell Sciences
    • ThermoGenesis
    • VetCell Bioscience

    LIST OF EXHIBITS

     

    CHAPTER ONE: EXECUTIVE SUMMARY

    • Table 1-2: Stem Cell Therapeutics Market in $ Millions, 2007-2020

    CHAPTER TWO: CURRENT STEM CELL THERAPIES

    • Table 2-1: Types of Leukemia, 2007

    CHAPTER THREE: DEVELOPMENTAL STEM CELL THERAPIES

    • Table 3-1: Global Disease Populations Addressed by Potential Stem Cell Therapies, 2007

       

    • Table 3-2: Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2007 and 2020

       

    • Table 3-3: Estimated and Projected World Cancer Mortality by Selected Types of Cancer, 2007 and 2020

       

    • Table 3-4: Types and Features of Urinary Incontinence, 2007

       

    • Table 3-5: Types and Causes of Male Infertility, 2007

       

    • Table 3-6: Common Diseases of the Lungs, 2007

    CHAPTER FOUR: STEM CELL MARKET FORECASTS

       

    • Table 4-1: Persons Affected by Key Stem Cell Therapeutic Targets in Millions, 2007

       

    • Table 4-2: Best Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020(Alzheimer’s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn’s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson’s Disease, Sickle Cell Disease)

       

    • Table 4-3: Best Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007 - 2020(Alzheimer’s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn’s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson’s Disease, Sickle Cell Disease)

       

    • Table 4-4: Most Likely Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020(Alzheimer’s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn’s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson’s Disease, Sickle Cell Disease)

       

    • Table 4-5: Most Likely Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007-2020(Alzheimer’s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn’s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson’s Disease, Sickle Cell Disease)

    CHAPTER FIVE: COMPANY PROFILES

    • Table 5-1: Therapeutic Focus of Selected Stem Cell Therapeutics Companies, 2007
    (来源: 互联网 )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, 时时彩网络平台,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。


  • 李克强:扩大跨省异地就医直接结算范围 2019-08-11
  • 次仁卓玛一家的端午节 2019-08-11
  • 市人大常委会召开党组会议传达学习全国两会精神张轩主持并讲话 2019-08-09
  • 世界杯期间在家撸串的正确姿势-热门标签-华商网数码 2019-08-06
  • 兴业银行获第十二届人民企业社会责任奖年度企业奖 2019-08-02
  • 宝马中国创新日暨上海研发中心揭幕 专注于高新技术 2019-08-01
  • 解放军报评论员:担当起党和人民赋予的新时代使命任务 2019-08-01
  • 别人家的中年男子 听音识木一把琴能卖30万 2019-07-18
  • 《贪婪之秋》延期至2019年 E3新宣传片公开 2019-06-25
  • 《关于发展租赁型职工集体宿舍的意见(试行)》正式发布实施 2019-06-24
  • 网约车陷阱多 谨防四类风险 2019-06-19
  • 太原设禁鸣路段 设备在测试中 2019-06-19
  • 歌浴森专辑写真曝光 俏皮可爱萌态十足 2019-06-09
  • 破11个赛季不胜魔咒 山东客场击败广厦 2019-06-09
  • 喝了6瓶劲酒和1斤白酒 男子手持钢锯在重庆西站撒泼遭控制 2019-06-01
  • 福建十三水图片 中原风采22选五走势图 江苏十一选五中奖号 腾讯分分彩注册送彩金 竟彩500网 23号青海快3走势 广东快乐10分彩票控 腾讯5分彩官方开奖数据 福彩3d豹子的奖金 3d图片 012期二肖中特 福建省31选7走势图 120期波叔一波中特图 双色球基本走势图2007 波克棋牌下载